Literature DB >> 18463877

MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings.

Gabriele Masselli1, Riccardo Manfredi, Amorino Vecchioli, Gianfranco Gualdi.   

Abstract

The primary aim was to evaluate delayed contrast-enhanced MRI in depicting perineural spread of hilar cholangiocarcinoma (CCC) and consequently to determine the capability of MRI/MRCP for staging CCC. Fifteen patients that underwent MRI/MRCP and surgical treatment were retrospectively included. Two radiologists evaluated MR images to assess delayed periductal enhancement, extent of bile duct stenosis, liver parenchymal and vascular involvement and presence of liver atrophy. An agreement between delayed enhancement of the bile duct walls and perineural neoplastic spread showed a very good correlation factor (0.93). The overall accuracy in detecting biliary neoplastic invasion was higher for delayed T1-weighted images (93.3%) than for the MRCP images (80%), and T1-delayed image increased the MR accuracy in assessing the neoplastic resectability (p<0.05). MRI correctly predicted vascular involvement in 73% and liver involvement in 80% of the cases. The number of overall correctly assessed patients with regard to resectability was 11 true positive, 1 false positive and 3 true negative. The combination of MRI/MRCP is a reliable diagnostic method for staging hilar cholangiocarcinomas. Delayed periductal enhancement is accurate in the evaluation of neoplastic perineural spread, and it can improve diagnostic accuracy to identify resectable and unresectable tumours.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463877     DOI: 10.1007/s00330-008-1004-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  30 in total

1.  Staging of hilar cholangiocarcinoma by ultrasound and duplex sonography: a comparison with angiography and operative findings.

Authors:  C Looser; S C Stain; H U Baer; J Triller; L H Blumgart
Journal:  Br J Radiol       Date:  1992-10       Impact factor: 3.039

2.  Carcinoma at the junction of the main hepatic ducts.

Authors:  M J Whelton; M Petrelli; P George; W B Young; S Sherlock
Journal:  Q J Med       Date:  1969-04

3.  Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.

Authors:  J A Guthrie; J Ward; P J Robinson
Journal:  Radiology       Date:  1996-11       Impact factor: 11.105

4.  Clinicopathologic studies on perineural invasion of bile duct carcinoma.

Authors:  M R Bhuiya; Y Nimura; J Kamiya; S Kondo; S Fukata; N Hayakawa; S Shionoya
Journal:  Ann Surg       Date:  1992-04       Impact factor: 12.969

5.  Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions.

Authors:  J E Lopera; J A Soto; F Múnera
Journal:  Radiology       Date:  2001-07       Impact factor: 11.105

6.  HASTE MR cholangiography in the evaluation of hilar cholangiocarcinoma.

Authors:  A S Fulcher; M A Turner
Journal:  AJR Am J Roentgenol       Date:  1997-12       Impact factor: 3.959

7.  Half-Fourier RARE MR cholangiopancreatography: experience in 300 subjects.

Authors:  A S Fulcher; M A Turner; G W Capps; A M Zfass; K M Baker
Journal:  Radiology       Date:  1998-04       Impact factor: 11.105

Review 8.  Magnetic resonance imaging of cholangiocarcinoma.

Authors:  Riccardo Manfredi; Brunella Barbaro; Gabriele Masselli; Amorino Vecchioli; Pasquale Marano
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

9.  Magnetic resonance cholangiography: comparison with endoscopic retrograde cholangiopancreatography.

Authors:  J A Soto; M A Barish; E K Yucel; D Siegenberg; J T Ferrucci; R Chuttani
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

10.  Biliary carcinoma. A review of 109 cases.

Authors:  F Alexander; R L Rossi; M O'Bryan; U Khettry; J W Braasch; E Watkins
Journal:  Am J Surg       Date:  1984-04       Impact factor: 2.565

View more
  28 in total

Review 1.  [Klatskin tumors: rational diagnostics and staging].

Authors:  U W Denzer; T Rösch
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

Review 2.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

Authors:  Murad Aljiffry; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

3.  Compliance with evidence-based multidisciplinary guidelines on perihilar cholangiocarcinoma.

Authors:  Robert Js Coelen; Joost Huiskens; Pim B Olthof; Eva Roos; Jimme K Wiggers; Annuska Schoorlemmer; Otto M van Delden; Heinz-Josef Klümpen; Erik Aj Rauws; Thomas M van Gulik
Journal:  United European Gastroenterol J       Date:  2016-09-30       Impact factor: 4.623

Review 4.  Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  A T Ruys; B E van Beem; M R W Engelbrecht; S Bipat; J Stoker; T M Van Gulik
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

Review 5.  Liver transplantation in the management of perihilar cholangiocarcinoma.

Authors:  Aliya F Gulamhusein; William Sanchez
Journal:  Hepat Oncol       Date:  2015-11-06

6.  Endoscopic diagnosis of extrahepatic bile duct carcinoma: Advances and current limitations.

Authors:  Kiichi Tamada; Jun Ushio; Kentaro Sugano
Journal:  World J Clin Oncol       Date:  2011-05-10

Review 7.  Cholangiocarcinoma - evolving concepts and therapeutic strategies.

Authors:  Sumera Rizvi; Shahid A Khan; Christopher L Hallemeier; Robin K Kelley; Gregory J Gores
Journal:  Nat Rev Clin Oncol       Date:  2017-10-10       Impact factor: 66.675

Review 8.  Current diagnostic and management options in perihilar cholangiocarcinoma.

Authors:  Sumera Rizvi; Gregory J Gores
Journal:  Digestion       Date:  2014-05-22       Impact factor: 3.216

Review 9.  Palliation: Hilar cholangiocarcinoma.

Authors:  Mahesh Kr Goenka; Usha Goenka
Journal:  World J Hepatol       Date:  2014-08-27

Review 10.  Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current status.

Authors:  Reiji Sugita
Journal:  World J Hepatol       Date:  2013-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.